Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2015 Sep;76(9):807-13.
doi: 10.2460/ajvr.76.9.807.

Attenuation of the Pressor Response to Exogenous Angiotensin by Angiotensin Receptor Blockers and Benazepril Hydrochloride in Clinically Normal Cats

Controlled Clinical Trial

Attenuation of the Pressor Response to Exogenous Angiotensin by Angiotensin Receptor Blockers and Benazepril Hydrochloride in Clinically Normal Cats

Tiffany L Jenkins et al. Am J Vet Res. .

Abstract

Objective: To compare the attenuation of the angiotensin I-induced blood pressure response by once-daily oral administration of various doses of angiotensin receptor blockers (irbesartan, telmisartan, and losartan), benazepril hydrochloride, or lactose monohydrate (placebo) for 8 days in clinically normal cats.

Animals: 6 healthy cats (approx 17 months old) with surgically implanted arterial telemetric blood pressure-measuring catheters.

Procedures: Cats were administered orally the placebo or each of the drug treatments (benazepril [2.5 mg/cat], irbesartan [6 and 10 mg/kg], telmisartan [0.5, 1, and 3 mg/kg], and losartan [2.5 mg/kg]) once daily for 8 days in a crossover study. Approximately 90 minutes after capsule administration on day 8, each cat was anesthetized and arterial blood pressure measurements were recorded before and after IV administration of each of 4 boluses of angiotensin I (20, 100, 500, and 1,000 ng/kg). This protocol was repeated 24 hours after benazepril treatment and telmisartan (3 mg/kg) treatment. Differences in the angiotensin I-induced change in systolic arterial blood pressure (ΔSBP) among treatments were determined.

Results: At 90 minutes after capsule administration, only losartan did not significantly reduce ΔSBP in response to the 3 higher angiotensin doses, compared with placebo. Among drug treatments, telmisartan (3 mg/kg dosage) attenuated ΔSBP to a significantly greater degree than benazepril and all other treatments. At 24 hours, telmisartan was more effective than benazepril (mean ± SEM ΔSBP, 15.7 ± 1.9 mm Hg vs 55.9 ± 12.42 mm Hg, respectively).

Conclusions and clinical relevance: Results indicated that telmisartan administration may have advantages over benazepril administration for cats with renal or cardiovascular disease.

Similar articles

See all similar articles

Cited by 4 articles

Publication types

MeSH terms

LinkOut - more resources

Feedback